|
About the Events / Workshops / Webinars category
|
|
0
|
760
|
April 14, 2021
|
|
🇺🇸 FDA FY26 GDUFA Public Workshop
|
|
21
|
837
|
June 28, 2026
|
|
The Future of Bio/Pharmaceutical Analysis 2026 - Nitrosamines
|
|
4
|
252
|
June 26, 2026
|
|
Nitrosamines & Genotoxic Impurities in Pharmaceutical Development and Manufacturing
|
|
3
|
344
|
June 21, 2026
|
|
Advancing Nitrosamine Analysis: USP Frameworks and LC-MS/MS Solutions
|
|
1
|
283
|
June 19, 2026
|
|
N-nitroso-Duloxetine recall back in the news!
|
|
22
|
5498
|
June 17, 2026
|
|
Advancing Generic Drug Development: Translating Science to Approval 2025
|
|
3
|
520
|
June 11, 2026
|
|
Fiscal Year 2026 Generic Drug Science and Research Initiatives Public Workshop
|
|
6
|
353
|
June 8, 2026
|
|
Nitrosamine Workshop, Hyderabad, August 19 & 20
|
|
2
|
231
|
May 19, 2026
|
|
Science-led approaches to nitrosamine qualification and safety assessment-webinar
|
|
1
|
213
|
May 15, 2026
|
|
FDA-CDER and HESI | Nitrosamine Ames Data Review and Method Development Workshop
|
|
2
|
401
|
May 6, 2026
|
|
Generic Drugs Forum (GDF) 2026
|
|
17
|
861
|
May 5, 2026
|
|
Benchmark Dose (BMD) Modeling for Risk Assessment webinar
|
|
1
|
309
|
May 4, 2026
|
|
🇺🇸 FDA Workshop - Nitrosamine-driven Reformulation and Bioequivelance
|
|
1
|
256
|
April 17, 2026
|
|
FDA CRCG Workshop on Bioequivalence Innovations for Generic Oral Products
|
|
0
|
115
|
April 11, 2026
|
|
N-Nitrosamine Risk Management: From Toxicology to Targeted Analysis-Webinar
|
|
1
|
327
|
April 7, 2026
|
|
Everthing you wanted to know about In vivo COMET assay -webinar
|
|
0
|
102
|
April 3, 2026
|
|
All are welcomed to participate in the Stakeholder Survey concerning a Potential USP Public Standard on Mutagenic Impurities
|
|
0
|
126
|
April 2, 2026
|
|
Register for Free Webinar- Australia and New Zealand: Nitrosamines Impurities 19 March 2026
|
|
0
|
234
|
March 10, 2026
|
|
Register for Quality Hour- Japan Edition: Nitrosamines Impurities 18 March 2026
|
|
0
|
236
|
March 8, 2026
|
|
The Bench Mark dose (BMD) - Recorded full two day training FREE
|
|
4
|
410
|
March 4, 2026
|
|
Podcast: Reducing Nitrosamines and Driving Patient Safety
|
|
0
|
152
|
February 23, 2026
|
|
Nitrites/Nitrosamines: The impacts on analytics, but not only
|
|
0
|
190
|
February 17, 2026
|
|
10th Impurities: Genotoxic, Nitrosamine, & Beyond Summit
|
|
2
|
403
|
February 2, 2026
|
|
Live Q&A hosted by Andy Teasdale
|
|
0
|
184
|
January 30, 2026
|
|
🇹🇷 USP is hosting a user event (and I will be there! 👨🔬)
|
|
4
|
315
|
January 20, 2026
|
|
🇪🇬 EDA Workshop: Nitrosamine Impurities, Risk Assessment, Control Strategies, and Regulatory Compliance
|
|
3
|
371
|
January 14, 2026
|
|
🇺🇸 FDA Information Session on Generic Drug Research Needs & Opportunities for FY 2026
|
|
0
|
271
|
January 12, 2026
|
|
Happy 2026 Nitroso-warrior!
|
|
5
|
492
|
January 9, 2026
|
|
Calling our Risk Assessment Experts
|
|
52
|
1803
|
December 30, 2025
|